IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy  Marc Humbert, MD, Jean Bousquet, MD, Claus Bachert, MD, Oscar Palomares, MD, Pascal Pfister, MD, Ioannis Kottakis, MD, Xavier Jaumont, MD, Simon Francis Thomsen, MD, Nikolaos G. Papadopoulos, MD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 7, Issue 5, Pages 1418-1429 (May 2019) DOI: 10.1016/j.jaip.2019.02.030 Copyright © 2018 The Authors Terms and Conditions

Figure 1 Immunological mechanisms in IgE-mediated allergic diseases. Th2 cell, T-helper-2 cell. The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 1418-1429DOI: (10.1016/j.jaip.2019.02.030) Copyright © 2018 The Authors Terms and Conditions

Figure 2 Multimorbidities associated with severe allergic asthma. ABPA, Allergic bronchopulmonary aspergillosis; CRSwNP, chronic rhinosinusitis with nasal polyps. The Journal of Allergy and Clinical Immunology: In Practice 2019 7, 1418-1429DOI: (10.1016/j.jaip.2019.02.030) Copyright © 2018 The Authors Terms and Conditions